Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by reconsideron Jul 09, 2024 9:35am
229 Views
Post# 36124192

RE:RE:Smart move by TLT management...

RE:RE:Smart move by TLT management...Normally, private placements are divided into tranches to cater to different investor preferences and the issuer's needs. In order to knock down the speculation TLT should have given us an estimated closure for the second tranche. It's common practice.
So let's keep the speculation going:
I would hope that Roger has capped the max dilution at $10M. He may have a deal with a bigger investor to fill the PP (minus the money raised from retail and insiders in this 1st tranche). That amount difference would define the conditions of the 2nd tranche.
One can dream. GLTA.

*Please TLT, better NRs. In this pursuit there are some many variables we have no control over. NRs that minimize uncertainty is something we can control. 
<< Previous
Bullboard Posts
Next >>